跳至主要内容
临床试验/NCT04266106
NCT04266106Unknown3 期

Effect of Perioperative Probiotics on Clinical Outcomes of Patients Undergoing Major Abdominal Operation in Community Settings - 2

Jan Franko, MD1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2020年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
发起方
入组人数
300
试验地点
1
主要终点
Quality of Life

研究概览

简要总结

This prospective randomized trial is designed to test a pragmatic simple intervention in a community hospital. The trial will test the hypothesis whether patient recovery after a major elective abdominal operation can be improved and/or accelerated with postoperative use of probiotics.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults aged ≥18 years undergoing elective major abdominal operation
  • Functional GI tract expected after operation

排除标准

  • Current episode of acute necrotizing pancreatitis as defined by surgeon
  • Palliative decompressive GI tube
  • Life expectancy ≤ 6 months
  • Systemic immune-mediated disease active requiring systemic therapy:
  • Prednisone ≥20 mg QD
  • IV immunoglobulins
  • Anti-rejection medication
  • Presence of functional transplanted organ
  • Systemic collagen-related disease treated with immunomodulating agents, including rheumatoid arthritis, SLE, scleroderma, etc.
  • Topical chemotherapy or corticosteroids, and chemotherapy applied during operation are allowed
  • Patient taking probiotics, synbiotics, or cobiotics as part of their lifestyle
  • Need for full systemic anticoagulation postoperatively.

研究组 & 干预措施

probiotic

Experimental

干预措施: SuperBio probiotic (Drug)

Placebo Comparator

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Quality of Life

时间窗: up to 2 months

Functional Assessment of Cancer Therapy (FACT) G7 score: higher value corresponds with better QoL, range 0-28 points

次要结局

未报告次要终点

研究者

发起方
Jan Franko, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jan Franko, MD

Chair of Surgical Oncology

MercyOne Des Moines Medical Center

研究点 (1)

Loading locations...

相似试验